The association between maternal diabetes, antidiabetic medication use, and severe ADHD requiring inpatient care: A

Yitayish Damtie1, Kim Betts2, Berihun Assefa Dachew3

  • 1School of Population Health, Faculty of Health Sciences, Curtin University, Australia; Department of Public Health, College of Medicine and Health Science, Injibara University, Injibara, Ethiopia.

Insights

Maternal diabetes and antidiabetic medication use during pregnancy did not increase the risk of severe Attention-deficit/hyperactivity disorder (ADHD) in children. Further research is needed to confirm the long-term neurodevelopmental safety of these medications.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatrics
  • Pharmacology

Background:

  • Limited evidence exists on the association between maternal antidiabetic medication use and child neurodevelopmental outcomes.
  • This study investigated the link between maternal diabetes, medication use, and severe Attention-deficit/hyperactivity disorder (ADHD) in offspring.

Purpose of the Study:

  • To examine the association between maternal diabetes during pregnancy and the risk of severe ADHD in children.
  • To assess the relationship between maternal antidiabetic medication use and offspring ADHD risk.

Main Methods:

  • Utilized linked health administrative data from New South Wales, Australia.
  • Identified maternal diabetes, antidiabetic medication use, and offspring ADHD using ICD-10-AM codes.
  • Employed binary logistic regression to calculate adjusted odds ratios (AOR) and 95% confidence intervals (CI).

Main Results:

  • Analyzed 229,785 mother-offspring pairs.
  • Maternal diabetes (any, GDM, pre-existing) was not associated with increased severe ADHD risk (e.g., any diabetes AOR=1.10, 95% CI: 0.84-1.45).
  • Antidiabetic medication use during pregnancy showed no significant link to ADHD (OR=1.17, 95% CI: 0.66-2.06).

Conclusions:

  • Findings do not support the hypothesis that prenatal exposure to antidiabetic medications independently increases severe ADHD risk.
  • Further research is necessary to fully understand the long-term neurodevelopmental safety of maternal antidiabetic medications.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
317
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
715
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
412